Corporate News

Bangkok Lab and Cosmetics Public Company Limited or BLC sent its subsidiary, Bangkok Drugs Company Limited, to enter into an agreement to receive the rights to distribute medicines of Nichi-Iko Company through the pharmacy channel in Thailand. Moving forward to increase access to good quality medicine and focus on selling drugs with international standards at an affordable price for Thai patients. Proactively create growth through Synergy by using BLC's expertise in the pharmaceutical market in Thailand with innovation and modern production technology from Japan.

Mr.Suwit Ngampuphan, Chief Executive Officer of Bangkok Lab and Cosmetics Public Company Limited or BLC, a manufacturer and distributor of pharmaceutical products, Generic drug, new generic drugs, herbal medicine , products for animals and comprehensive health products. Food supplement, Cosmetics and Other components. Revealed that the group of companies aims to create continuous growth. One of the organization's key strategies is to create joint growth with business partners or Alliances to drive sustainable growth together.

Recently, Bangkok Drug Company Limited or BDC under the BLC group of companies has reached an agreement with Nichi-Iko Company to obtain the rights to distribute medicines. Through the exclusive pharmacy channel in Thailand. To expand distribution channels Through BDC who has a marketing and sales team with expertise in the pharmaceutical industry in Thailand for a long time. And also has a good relationship with drugstore networks in Thailand. It will begin distribution from April 2024. The first phase focuses on distributing Antihyperlipidemic drugs, Antiasthma drugs, Antihypertension drugs and Antibacterial eye drops, etc. and plans to continuously expand the product portfolio. It is expected that there will be at least 5-10 products waiting to be registered in Thailand for distribution to market within 5 years. Nichi-Iko will also be a distributor in the hospital channel. both public and private hospitals and clinics.

BLC Chief Executive Officer revealed that the right to distribute exclusively through drugstore channels in Thailand this time. It will help increase the opportunity to expand business with partners in the future. . It is considered an opportunity to increase access to good quality medicine for Thai It will also help create sustainable mutual growth in the pharmaceutical industry.

In order to support business expansion and create growth from this cooperation, the company has established another business operations team consisting of personnel with long experience and expertise in the industry. It had start operations in January 2024 to drive growth to achieve the goals set.

For Nichi-Iko Company, which considered a leading manufacturer and distributor of generic pharmaceutical products from Japan. Focus on the important mission of supporting quality of life. Health and happiness of people around the world. Therefore, the business has been expanded to Thailand since 2014 to become a base for business in the ASEAN region. In Thailand There is a product group including Antihyperlipidemic drugs, Antiasthma drugs, Antihypertension drugs and Antibacterial eye drops and medicine to treat lung cancer. Which has unique and modern production technology It has international standards GMP/PICS and also has production technology to help with safe for patients, such as using laser printing technology on tablets that are safe to delivered. Make the pills have markings that can identified. and has a number indicating the strength of the drug. As well as patient-friendly packaging technology, such as adjusting the unit dose medicine blister to have dotted markings to make it easier to divided. Developing shape of eyedrop bottles to reduce the rolling and slip of medicine bottles that may slip out of the patient's hand and fall to the floor, etc.

“For more than 30 years, BLC has operated its business with the aim of creating good health and well-being for people in all sectors. Collaborating with a business partner, a leading pharmaceutical company from Japan like Nichi-Iko, which has innovation and modern production technology. This, combined with BLC's expertise in the Thai pharmaceutical market, will help increase access to good quality medicines. There are international standards. at a reasonable price for the Thai people to create sustainable health in the long term,” said Dr. Suwit.